Oct 15, 2019· Comment from Association for Accessible Medicines (AAM)· FDA-2019-D-2397-0012
Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies regarding FDA-2019-D-2397: Using the Inactive Ingredient Database.